Kairos Biotech
Denbigh
About Kairos Biotech
Kairos Biotech is an early stage company focusing on proprietary small molecule discovery applied to diagnostics and immunotherapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Seed (Feb 2023)
- Website: kairosbiotech.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kairos-biotech-142915 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.